Results 101 to 110 of about 833,606 (316)

Faire, faire faire

open access: yes, 2016
Dans les planches de l’Encyclopédie, le voir ouvre l’accès universel au savoir. La beauté du mécanisme est un modèle d’intelligibilité, et à ce titre elle contribue à opposer les connaissances scientifiques à toutes sortes de savoirs occultes. La machine est en effet comparable à l’œuvre d’art en tant qu’un faire intelligent, tandis que les machines d ...
openaire   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

Digitally Enlightened or Still in the Dark? Establishing a Sector-Wide Approach to Enhancing Data Synthesis and Research Potential in British Environmental Archaeology and Beyond

open access: yesInternet Archaeology
In a 2019 Internet Archaeology article, Elizabeth Pearson posed the question 'are we back in the Dark Ages?'. This question was made in reference to a developer-funded archaeology sector that was generating vast quantities of evidence and, particularly ...
Tina Roushannafas   +8 more
doaj   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

State Fair of Texas, Dallas, Texas, September 30 to October 15, 1905

open access: yes, 1905
Publication of announcement of State Fair of Texas.Cover ...
Unknown
core  

Implementing fair lending practices: Advanced data analytics approaches and regulatory compliance

open access: yes
Implementing fair lending practices is crucial for financial institutions to ensure equal access to credit and comply with regulatory requirements. Advanced data analytics approaches offer powerful tools for detecting and mitigating potential biases in ...
Oluwaseun Adeola Bakare   +2 more
core   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

The Kendall County Fair : catalogue and prize list.

open access: yes, 1924
Content warning: this item contains racist or offensive language.
Kendall County Fair (Boerne, Tex.)
core  

A model for publishers to introduce globally fair and transparent pricing

open access: yesInsights: The UKSG Journal
The transition of many academic journals from the subscription model to open access shifts payment for publishing services from readers to producers of knowledge.
Alicia Wise   +3 more
doaj   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy